Haleon PLC Directorate Change
01 Mai 2024 - 12:10PM
RNS Regulatory News
RNS Number : 8322M
Haleon PLC
01 May 2024
Haleon plc announces changes
to the Board
1
May 2024: Haleon plc (the "Company"
or "Haleon") (LSE/NYSE: HLN)
today announces that following Deirdre Mahlan's
appointment as President, Chief Executive
Officer and Chairperson of the Board of The Duckhorn Portfolio, Inc. (NYSE: NAPA),
Deirdre will be stepping down from her role as Non-Executive
Director and Chair of the Audit & Risk Committee of Haleon.
Deirdre has agreed to continue as Non-Executive Director and Chair
of the Audit & Risk Committee of Haleon until a successor has
been identified.
Sir
Dave Lewis, Haleon's Chair commented: "On behalf of the Board, I would like to thank Deirdre for her
considerable contributions to the Board and for chairing the Audit
& Risk Committee. I wish her all the best for the future. A
search for her successor is now underway."
Contacts
Zoë
Bird
+44 7736 746167
Sonya
Ghobrial +44 7392 784784
Email: corporate.media@haleon.com
About Haleon
Haleon (LSE / NYSE: HLN) is a global
leader in consumer health, with a purpose to deliver better
everyday health with humanity. Haleon's product portfolio spans
five major categories - Oral Health, Pain Relief, Respiratory
Health, Digestive Health and Other, and Vitamins, Minerals and
Supplements (VMS). Its long-standing brands - such as Advil,
Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident,
parodontax and Centrum - are built on trusted science, innovation
and deep human understanding.
For more information, please
visit www.haleon.com.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
BOAUPUMUAUPCGUG
Haleon (LSE:HLN)
Historical Stock Chart
Von Apr 2024 bis Mai 2024
Haleon (LSE:HLN)
Historical Stock Chart
Von Mai 2023 bis Mai 2024